Eledon Pharmaceuticals (ELDN) Research & Development (2013 - 2026)
Eledon Pharmaceuticals posted quarterly Research & Development of $17.2 million for Q1 2026, up 27.09% year-on-year from $13.5 million in Q1 2025, and up 14.88% on a QoQ basis from $15.0 million in Q3 2025.
Eledon Pharmaceuticals (ELDN) has 14 years of Research & Development data on file, last reported at $17.2 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 27.09% year-over-year to $17.2 million; the trailing twelve-month figure through Mar 2026 stood at $66.0 million (up 13.58% YoY), and the FY2024 full-year result was $52.0 million, up 71.43% from the prior year.
- Research & Development for Q1 2026 stood at $17.2 million, up from $15.0 million in the prior quarter.
- Across five years, Research & Development topped out at $20.3 million in Q2 2025 and bottomed at $5.7 million in Q2 2022.
- The 5-year median for Research & Development is $8.0 million (2023), against an average of $11.0 million.
- The widest annual swing landed in 2024, when Research & Development surged 153.69%; it then decreased 9.39% in 2025.
- A 5-year view of Research & Development shows it stood at $7.2 million in 2022, then fell by 2.52% to $7.1 million in 2023, then soared by 153.69% to $17.9 million in 2024, then decreased by 16.5% to $15.0 million in 2025, then climbed by 14.88% to $17.2 million in 2026.
- The last three Research & Development figures came in at $17.2 million (Q1 2026), $15.0 million (Q3 2025), and $20.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | 17.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.20 Mn |
| Sep 30, 2025 | 14.97 Mn |
| Jun 30, 2025 | 20.28 Mn |
| Mar 31, 2025 | 13.53 Mn |
| Dec 31, 2024 | 17.93 Mn |
| Sep 30, 2024 | 16.52 Mn |
| Jun 30, 2024 | 10.11 Mn |
| Mar 31, 2024 | 7.41 Mn |
| Dec 31, 2023 | 7.07 Mn |
| Sep 30, 2023 | 7.93 Mn |
| Jun 30, 2023 | 7.20 Mn |
| Mar 31, 2023 | 8.11 Mn |
| Dec 31, 2022 | 7.25 Mn |
| Sep 30, 2022 | 7.45 Mn |
| Jun 30, 2022 | 5.74 Mn |
| Mar 31, 2022 | 6.64 Mn |
| Dec 31, 2021 | 6.18 Mn |
| Sep 30, 2021 | 7.66 Mn |
| Jun 30, 2021 | 4.24 Mn |
| Mar 31, 2021 | 5.65 Mn |
| Dec 31, 2020 | 3.04 Mn |
| Sep 30, 2020 | 615,000.00 |
| Jun 30, 2020 | 832,000.00 |
| Mar 31, 2020 | 1.65 Mn |
| Dec 31, 2019 | 1.33 Mn |
| Sep 30, 2019 | 1.51 Mn |
| Jun 30, 2019 | 2.30 Mn |
| Mar 31, 2019 | 2.99 Mn |
| Dec 31, 2018 | 2.74 Mn |
| Sep 30, 2018 | 1.65 Mn |
| Jun 30, 2018 | 1.33 Mn |
| Mar 31, 2018 | 1.10 Mn |
| Dec 31, 2017 | 493,000.00 |
| Sep 30, 2017 | 517,000.00 |
| Jun 30, 2017 | 533,000.00 |
| Mar 31, 2017 | 479,000.00 |
| Dec 31, 2016 | 856,000.00 |
| Sep 30, 2016 | 1.05 Mn |
| Jun 30, 2016 | 592,000.00 |
| Mar 31, 2016 | 7.93 Mn |
| Dec 31, 2015 | 7.73 Mn |
| Sep 30, 2015 | 8.49 Mn |
| Jun 30, 2015 | 5.86 Mn |
| Mar 31, 2015 | 10.56 Mn |
| Dec 31, 2014 | 3.80 Mn |
| Sep 30, 2014 | 2.83 Mn |
| Jun 30, 2014 | 4.39 Mn |
| Mar 31, 2014 | 3.56 Mn |
| Dec 31, 2013 | 4.35 Mn |
| Sep 30, 2013 | 2.70 Mn |